HK1156310A1 - Thiazolyl- and oxazolyl-isoquinolinones and methods for using them - Google Patents

Thiazolyl- and oxazolyl-isoquinolinones and methods for using them

Info

Publication number
HK1156310A1
HK1156310A1 HK11110561.5A HK11110561A HK1156310A1 HK 1156310 A1 HK1156310 A1 HK 1156310A1 HK 11110561 A HK11110561 A HK 11110561A HK 1156310 A1 HK1156310 A1 HK 1156310A1
Authority
HK
Hong Kong
Prior art keywords
isoquinolinones
oxazolyl
thiazolyl
methods
Prior art date
Application number
HK11110561.5A
Other languages
English (en)
Chinese (zh)
Inventor
Roberto Pellicciari
Flavio Moroni
Adam M Gilbert
Original Assignee
Roberto Pellicciari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roberto Pellicciari filed Critical Roberto Pellicciari
Publication of HK1156310A1 publication Critical patent/HK1156310A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK11110561.5A 2008-06-19 2011-10-06 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them HK1156310A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7385708P 2008-06-19 2008-06-19
PCT/US2009/047767 WO2009155402A1 (en) 2008-06-19 2009-06-18 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them

Publications (1)

Publication Number Publication Date
HK1156310A1 true HK1156310A1 (en) 2012-06-08

Family

ID=41087350

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11110561.5A HK1156310A1 (en) 2008-06-19 2011-10-06 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
HK16100665.6A HK1212698A1 (zh) 2008-06-19 2016-01-21 噻唑基和噁唑基異喹哪啶以及它們的使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16100665.6A HK1212698A1 (zh) 2008-06-19 2016-01-21 噻唑基和噁唑基異喹哪啶以及它們的使用方法

Country Status (12)

Country Link
US (3) US8299090B2 (sr)
EP (2) EP2303895B1 (sr)
JP (2) JP5564495B2 (sr)
AR (1) AR072265A1 (sr)
AU (1) AU2009260060B2 (sr)
CA (1) CA2728454C (sr)
DK (1) DK2303895T3 (sr)
ES (1) ES2530815T3 (sr)
HK (2) HK1156310A1 (sr)
SA (1) SA109300394B1 (sr)
TW (1) TWI471329B (sr)
WO (1) WO2009155402A1 (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8633215B2 (en) 2008-06-19 2014-01-21 Roberto Pellicciari Thienyl-and furanyl-isoquinolinones and methods for using them
SA109300394B1 (ar) * 2008-06-19 2013-01-22 ويث ثيازوليل- وأوكسازوليل- أيزوكوينولينونات وطرق لاستخدامها
JP2014520776A (ja) 2011-07-04 2014-08-25 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 植物における非生物的ストレスに対する活性薬剤としての置換されているイソキノリノン類、イソキノリンジオン類、イソキノリントリオン類およびジヒドロイソキノリノン類または各場合でのそれらの塩の使用
CN103703002B (zh) * 2011-07-13 2016-05-11 参天制药株式会社 具有parp抑制活性的新型化合物
CN108138177B9 (zh) 2015-07-23 2021-08-13 法国居里学院 Dbait分子与PARP抑制剂的组合用于治疗癌症的用途
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
WO2018162439A1 (en) 2017-03-08 2018-09-13 Onxeo New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule
US20200407720A1 (en) 2018-03-13 2020-12-31 Onxeo A dbait molecule against acquired resistance in the treatment of cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0005745B1 (en) * 1978-05-26 1982-07-14 Gruppo Lepetit S.P.A. Pyrazolo (3,4-c) and thiazolo (5,4-c) isoquinolines, methods for preparing them, these compounds for use as antiinflammatory, cns-depressant and anti-anxiety agents and pharmaceutical compositions thereof
ITMI20002358A1 (it) * 2000-10-31 2002-05-01 Flavio Moroni Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
AUPS137402A0 (en) * 2002-03-26 2002-05-09 Fujisawa Pharmaceutical Co., Ltd. Novel tricyclic compounds
ATE540928T1 (de) * 2002-11-22 2012-01-15 Mitsubishi Tanabe Pharma Corp Isochinolinverbindungen und ihre medizinische verwendung
US7696255B2 (en) 2005-08-01 2010-04-13 Wietek Holding Gmbh Process for the recycling of plastics
MX2008016339A (es) * 2006-06-20 2009-01-16 Abbott Lab Pirazoloquinazolinonas en la forma de inhibidores parp.
US8633215B2 (en) * 2008-06-19 2014-01-21 Roberto Pellicciari Thienyl-and furanyl-isoquinolinones and methods for using them
SA109300394B1 (ar) * 2008-06-19 2013-01-22 ويث ثيازوليل- وأوكسازوليل- أيزوكوينولينونات وطرق لاستخدامها

Also Published As

Publication number Publication date
JP2011525185A (ja) 2011-09-15
CA2728454A1 (en) 2009-12-23
US8906935B2 (en) 2014-12-09
EP2896626A1 (en) 2015-07-22
ES2530815T3 (es) 2015-03-05
US20150133443A1 (en) 2015-05-14
US9265769B2 (en) 2016-02-23
AU2009260060B2 (en) 2015-01-22
TW201002725A (en) 2010-01-16
US20130059843A1 (en) 2013-03-07
AR072265A1 (es) 2010-08-18
JP5564495B2 (ja) 2014-07-30
TWI471329B (zh) 2015-02-01
EP2303895B1 (en) 2014-09-24
DK2303895T3 (en) 2015-01-12
JP2014122242A (ja) 2014-07-03
CA2728454C (en) 2017-01-17
EP2303895A1 (en) 2011-04-06
US20090318442A1 (en) 2009-12-24
SA109300394B1 (ar) 2013-01-22
WO2009155402A1 (en) 2009-12-23
AU2009260060A1 (en) 2009-12-23
HK1212698A1 (zh) 2016-06-17
US8299090B2 (en) 2012-10-30

Similar Documents

Publication Publication Date Title
EP2308884A4 (en) PROCESS FOR THE PREPARATION OF HETEROSUBSTITUTED ALKYLHALOHYDROSILANE AND ITS USE
EP2259796A4 (en) MATERIALS AND METHODS FOR IMPROVED IMMUNE LYCOPROTEINS
EP2377154A4 (en) INTERCONNECT HOLE STRUCTURE AND ASSOCIATED METHOD
GB0818093D0 (en) Method
GB0803107D0 (en) Method
HK1212698A1 (zh) 噻唑基和噁唑基異喹哪啶以及它們的使用方法
GB2471221B (en) Methods
GB0818650D0 (en) Methods
GB0810418D0 (en) Method
GB0807409D0 (en) Method
GB0815428D0 (en) Method
GB0813599D0 (en) Method
GB0807410D0 (en) Method
GB0804981D0 (en) Method
GB0804690D0 (en) Method
GB0809404D0 (en) Method
EP2321435A4 (en) WIEDERAUFKOHLUNGSVERFAHREN
GB0811360D0 (en) Methods
GB0823333D0 (en) Apparatus and methods
GB0812559D0 (en) Method
GB0805862D0 (en) Method
GB0813494D0 (en) Method
GB0812102D0 (en) Method
GB0823408D0 (en) Apparatus and methods
GB0806186D0 (en) Method